We are live on
!
Find out more
NCM
Nantahala Capital Management Portfolio holdings
AUM
$2.72B
1-Year Est. Return
121.58%
This Fund
S&P 500
This Quarter
Est. Return
+12.61%
1 Year Est. Return
+121.58%
3 Year Est. Return
+308.64%
5 Year Est. Return
+308.9%
10 Year Est. Return
+2,888.73%
AUM
$1.31B
AUM Growth
-$238M
(-15%)
Cap. Flow
-$311M
Cap. Flow
% of AUM
-23.85%
Top 10 Holdings %
Top 10 Hldgs %
52.69%
Holding
138
New
20
Increased
29
Reduced
47
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
uniQure
QURE
|
+$7.76M |
| 2 |
CVT
Cvent Holding Corp. Common Stock
CVT
|
+$6.1M |
| 3 |
APEN
Apollo Endosurgery, Inc.
APEN
|
+$5.13M |
| 4 |
ILPT
Industrial Logistics Properties Trust
ILPT
|
+$4.93M |
| 5 |
IMAX
IMAX
|
+$4.42M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$92.1M |
| 2 |
TA
TravelCenters of America LLC
TA
|
+$28.5M |
| 3 |
PAYA
Paya Holdings Inc. Class A Common Stock
PAYA
|
+$19.4M |
| 4 |
CNCE
Concert Pharmaceuticals, Inc.
CNCE
|
+$10.1M |
| 5 |
Alta Equipment Group
ALTG
|
+$9.43M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.41% |
| 2 | Consumer Discretionary | 14.33% |
| 3 | Communication Services | 6.54% |
| 4 | Financials | 5.4% |
| 5 | Industrials | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
AYTU BioPharma
AYTU
$25.4M
| $608K | 0.05% |
+271,595
| New | +$795K |
|
|
IDW
102
DELISTED
IDW Media Holdings
IDW
| $592K | 0.05% |
822,537
-13,482
| -2% | -$12.5K |
|
103
Elicio Therapeutics
ELTX
$80.9M
| $541K | 0.04% |
98,274
-5,041
| -5% | -$33.6K |
|
104
Hyperfine
HYPR
$99.7M
| $531K | 0.04% |
368,417
-176,513
| -32% | -$216K |
|
105
CALL
Keros Therapeutics
KROS
$212M
| $525K | 0.04% |
12,300
-29,600
| -71% | -$1.49M |
|
|
EBET
106
DELISTED
EBET, INC. Common Stock
EBET
| $438K | 0.03% |
+35,514
| New | +$596K |
|
107
Lucid Diagnostics
LUCD
$185M
| $377K | 0.03% |
261,664
-17,873
| -6% | -$24.7K |
|
108
Transact Technologies
TACT
$58.2M
| $376K | 0.03% |
60,789
-4,949
| -8% | -$34.3K |
|
109
Journey Medical
DERM
$179M
| $333K | 0.03% |
212,357
-13,639
| -6% | -$25.4K |
|
110
Cue Biopharma
CUE
$107M
| $333K | 0.03% |
3,110
| – | – |
|
111
Exagen
XGN
$167M
| $322K | 0.02% |
132,613
-13,946
| -10% | -$36.1K |
|
|
BMTX
112
DELISTED
BM Technologies, Inc.
BMTX
| $279K | 0.02% |
79,212
-228,564
| -74% | -$925K |
|
|
EAR
113
DELISTED
Eargo, Inc. Common Stock
EAR
| $253K | 0.02% |
+54,002
| New | +$449K |
|
|
BACK
114
DELISTED
IMAC Holdings, Inc. Common Stock
BACK
| $149K | 0.01% |
34,669
-4,473
| -11% | -$32.4K |
|
115
Curis
CRIS
$4.68M
| $137K | 0.01% |
577
-1,414
| -71% | -$373K |
|
116
Rafael Holdings
RFL
$98.8M
| $113K | 0.01% |
73,695
| – | – |
|
|
LSDI
117
DELISTED
Lucy Scientific Discovery Inc. Common Stock
LSDI
| $105K | 0.01% |
+9,580
| New | +$177K |
|
118
Gaia
GAIA
$32.4M
| $64.3K | ﹤0.01% |
+23,144
| New | +$70.1K |
|
119
Fulcrum Therapeutics
FULC
$283M
| $60.9K | ﹤0.01% |
21,370
-478,630
| -96% | -$4.29M |
|
120
Gyre Therapeutics
GYRE
$711M
| $33.2K | ﹤0.01% |
10,695
-47,712
| -82% | -$181K |
|
121
Guardforce AI Warrant
GFAIW
$60K
| $30.9K | ﹤0.01% |
154,205
| – | – |
|
|
TCBPW
122
DELISTED
TC BioPharm (Holdings) plc Warrants
TCBPW
| $23.5K | ﹤0.01% |
235,294
| – | – |
|
|
QTEKW
123
DELISTED
QualTek Services Inc. Warrant
QTEKW
| $2.92K | ﹤0.01% |
96,244
| – | – |
|
124
Intellicheck
IDN
$76.3M
| – | – |
-124,594
| Closed | -$249K |
|
125
Liquidia Corp
LQDA
$8.02B
| – | – |
-146,792
| Closed | -$935K |
|
Similar funds
TAM
XL
NB
PA
BCM
SCM
HCM
GC
Nantahala Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Nantahala Capital Management held 138 positions worth $1.31B, down 15% from $1.54B the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Nantahala Capital Management withdrew a net $311M in Q1 2023, closing 14 positions and reducing 47 holdings. Its most notable exit was Paya Holdings Inc. Class A Common Stock, an estimated $19.4M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, Nantahala Capital Management opened a new position in Cvent Holding Corp. Common Stock worth $7.06M.
- Nantahala Capital Management's largest Q1 2023 buy was Cvent Holding Corp. Common Stock: 845,000 shares worth $7.06M.
- Nantahala Capital Management added most to uniQure in Q1 2023, an estimated $7.76M increase.
- Nantahala Capital Management's biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $92.1M.
- Nantahala Capital Management fully exited Paya Holdings Inc. Class A Common Stock in Q1 2023, selling an estimated $19.4M.
- Nantahala Capital Management's ten largest holdings make up 53% of its $1.31B portfolio in Q1 2023.
- Nantahala Capital Management opened 20 new positions and closed 14 in Q1 2023.
- Nantahala Capital Management's portfolio value fell 15% quarter-over-quarter to $1.31B.
Based on Nantahala Capital Management's 13F filing for Q1 2023, filed 15 May 2023.